Chemical Inhibition of JAK2 Mimics Genetic Ablation of Uterine Function of Leukemia Inhibitory Factor

Jrgang Cheng

Authors

Jrgang Cheng

Keywords:

leukemia inhibitory factor (LIF), implantation, janus kinase 2 (Jak2), tyrphostin, AG490, DMSO, signal transduction, contraception

Abstract

Uterine receptivity needs to be synchronized with embryonic development, so the blastocyst stage of the embryo can implant. Leukemia Inhibitory Factor (LIF) is an essential factor for implantation, which is involved in the initiation of the window of implantation. However, the process by which the LIF signal pathway is transduced in the uterine luminal epithelium (LE) that leads to uterine receptivity is not completely elucidated. We tested the ability of cellular signaling inhibitors to disrupt uterine support of the embryo. Only Tyrphostin-AG490, an inhibitor of Jak2, can interfere with LIF signaling. Not only can AG490 reduce phosphorylated STAT3 levels in isolated LE, but it also ablated implantation when injected into uterine lumen. Furthermore, AG490 treatment in wild-type animals mimics the consequences of genetic ablation of LIF that results in free floating hatched embryos, which are unable to implant. Our results support the notion that Jak2 is the sole Janus kinase to mediate LIF activation in LE, and the signaling pathways of cytokines can serve as contraception targets.

Downloads

How to Cite

Chemical Inhibition of JAK2 Mimics Genetic Ablation of Uterine Function of Leukemia Inhibitory Factor. (2016). Global Journal of Medical Research, 16(K2), 13-20. https://medicalresearchjournal.org/index.php/GJMR/article/view/1170

Download Citation

References

B Paria, H Song, S Dey (2001) Implantation: molecular basis of embryo-uterine dialogue. 45(3), 597-605.

C Finn, L Martin (1974) THE CONTROL OF IMPLANTATION. 39(1), 195-206.

J Mccormack, G Greenwald (1974) Progesterone and oestradiol-17beta concentrations in the peripheral plasma during pregnancy in the mouse. 62, 101-107.

J Mccormack, G Greenwald (1974) Evidence for a preimplantation rise in oestradiol-17beta levels on day 4 of pregnancy in the mouse. 41, 297-301.

J Chen, J Cheng, T Shatzer, L Sewell, L Hernandez, C Stewart (2000) Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis. 141, 4365-4372.

Colin Stewart, Petr Kaspar, Lisa Brunet, Harshida Bhatt, Inder Gadi, Frank Köntgen, Susan Abbondanzo (1992) Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. 359(6390), 76-79.

S Kimber (2005) Leukaemia inhibitory factor in implantation and uterine biology. 130, 131-145.

J Cheng, J Chen, L Hernandez, W Alvord, C Stewart (2001) Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation. 98, 8680-8685.

J Cheng, C Rodriguez, C Stewart (2002) Control of uterine receptivity and embryo implantation by steroid hormone regulation of LIF production and LIF receptor activity: towards a molecular understanding of "the window of implantation. 3, 119-126.

M Ernst, A Oates, A Dunn (1996) Gp130-mediated signal transduction in embryonic stem cells involves activation of Jak and Ras/mitogen-activated protein kinase pathways. 271, 30136-30143.

C Auernhammer, S Melmed (2000) Leukemiainhibitory factor-neuroimmune modulator of endocrine function. 21, 313-345.

R Bigsby, P Cooke, G Cunha (1986) A simple efficient method for separating murine uterine epithelial and mesenchymal cells. 251, 630-636.

T Boulton, Z Zhong, Z Wen, J Darnell, N Stahl, G Yancopoulos (1995) STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7sensitive kinase. 92, 6915-6919.

M Narazaki, B Witthuhn, K Yoshida, O Silvennoinen, K Yasukawa, J Ihle, T Kishimoto, T Taga (1994) Activation of JAK2 kinase mediated by the V. Acknowledgments.